3-hydroxyflavone has been researched along with Hepatocellular Carcinoma in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (20.83) | 29.6817 |
| 2010's | 14 (58.33) | 24.3611 |
| 2020's | 5 (20.83) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, Y; Mei, F; Zheng, S | 1 |
| Kozawa, O; Matsushima-Nishiwaki, R; Yamada, N | 1 |
| Panneerselvam, L; Perumal, E; Raghunath, A; Sundarraj, K | 1 |
| Dai, W; Jiang, L; Li, M; Li, Z; Yang, Y; Ye, WC | 1 |
| Bi, Y; Chen, J; Fu, J; Liu, B; Wang, X; Xia, T; Zhu, R | 1 |
| Liu, GL; Liu, XF; Long, HJ; Miao, XY; Yao, HL | 1 |
| Duan, J; He, YF; He, YH; Li, MY; Liang, YR; Lu, CJ; Xiang, LJ; Yuan, WZ; Zhang, J | 1 |
| Maurya, BK; Trigun, SK | 2 |
| Chen, Q; Fan, X; Li, J; Peng, Y; Pu, W; Shen, X; Wang, C; Wu, X; Yang, SY; Yu, Y; Zheng, Y; Zhou, Q | 1 |
| Hu, M; Huang, H; Li, M; Li, P; Zhao, R | 1 |
| Cao, Y; Chen, N; Chen, X; Li, M; Liu, B; Liu, J; Lu, C; Xia, J; Zhang, C; Zhang, Q; Zhu, R | 1 |
| Li, MY; Li, R; Liu, B; Liu, J; Liu, ZK; Miao, HL; Qiu, ZD; Shu, Y; Wang, DJ; Zeng, GF; Zhang, QY; Zhu, RZ | 1 |
| Bao, S; Chen, N; Chen, X; Chen, Y; Li, M; Liu, B; Liu, J; Xu, F; Zhang, Q; Zhou, W; Zhu, R | 1 |
| Jiang, L; Li, M; Liang, J; Liu, B; Liu, J; Lu, C; Ma, S; Ren, H; Zhang, Q; Zhu, R | 1 |
| Barros, L; Calhelha, RC; Carvalho, AM; Dias, MI; Ferreira, IC; Graça, VC; Santos, PF; Santos-Buelga, C | 1 |
| Chang, JJ; Li, LJ; Li, X; Lu, R; Sun, X; Wang, QL; Xie, WD; Zhao, XX | 1 |
| Aristizabal, F; Barrios, J; Cordero, CP; Heredia, FJ; Morales, AL; Osorio, C | 1 |
| Choi, KC; Chung, WT; Jang, YS; Kwon, JK; Lee, JC; Lee, SY; Park, SM; Yu, JY | 1 |
| Casaschi, A; Maiyoh, GK; Rubio, BK; Theriault, AG | 1 |
| Lu, YH; Tao, XY; Teng, BS; Wang, ZT; Wei, DZ | 1 |
| Konta, L; Révész, K; Tüttô, A | 1 |
| Fung, KP; Gao, JL; Lee, SM; Sa, F; Wang, YT; Zheng, Y | 1 |
| Chen, YC; Ko, CH; Lee, WR; Lin, HY; Shen, SC; Shih, CM; Yang, LL | 1 |
2 review(s) available for 3-hydroxyflavone and Hepatocellular Carcinoma
| Article | Year |
|---|---|
Molecular mechanisms and therapeutic implications of dihydromyricetin in liver disease.
Topics: Carcinoma, Hepatocellular; Flavonols; Humans; Liver Diseases; Liver Diseases, Alcoholic; Liver Failure, Acute; Liver Neoplasms; Liver Regeneration; Non-alcoholic Fatty Liver Disease; Protective Agents | 2021 |
[Effect of green tea flavonols on the function of the endoplasmic reticulum].
Topics: alpha-Glucosidases; Animals; Antineoplastic Agents; Apoptosis; Blood Glucose; Carcinoma, Hepatocellular; Catechin; Cell Line, Tumor; Endoplasmic Reticulum; Flavonols; Glucuronides; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Liver; Liver Neoplasms; Microsomes; Tea | 2007 |
22 other study(ies) available for 3-hydroxyflavone and Hepatocellular Carcinoma
| Article | Year |
|---|---|
Rhamnazin Inhibits Hepatocellular Carcinoma Cell Aggressiveness in Vitro via Glutathione Peroxidase 4-Dependent Ferroptosis.
Topics: Carcinoma, Hepatocellular; Ferroptosis; Flavonols; Glutathione Peroxidase; Humans; Liver Neoplasms; Phospholipid Hydroperoxide Glutathione Peroxidase | 2022 |
Quercetin suppresses the migration of hepatocellular carcinoma cells stimulated by hepatocyte growth factor or transforming growth factor-α: Attenuation of AKT signaling pathway.
Topics: Carcinoma, Hepatocellular; Cell Movement; Cell Proliferation; Flavonols; Gene Expression Regulation, Neoplastic; Hepatocyte Growth Factor; Humans; Liver Neoplasms; p38 Mitogen-Activated Protein Kinases; Phosphatidylinositol 3-Kinases; Phosphorylation; Proto-Oncogene Proteins c-akt; Quercetin; Signal Transduction; Transforming Growth Factor alpha | 2020 |
Fisetin Inhibits Autophagy in HepG2 Cells via PI3K/Akt/mTOR and AMPK Pathway.
Topics: AMP-Activated Protein Kinases; Apoptosis; Autophagy; Carcinoma, Hepatocellular; Flavonols; Hep G2 Cells; Humans; Liver Neoplasms; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; TOR Serine-Threonine Kinases | 2021 |
Anticancer effects of dihydromyricetin on the proliferation, migration, apoptosis and in vivo tumorigenicity of human hepatocellular carcinoma Hep3B cells.
Topics: Animals; Apoptosis; Carcinogenesis; Carcinoma, Hepatocellular; Cell Movement; Cell Proliferation; Flavonols; Humans; In Vitro Techniques; Liver Neoplasms; Mice; Mice, Nude; Random Allocation | 2021 |
Fisetin inhibits liver cancer growth in a mouse model: Relation to dopamine receptor.
Topics: Animals; Apoptosis; Carcinoma, Hepatocellular; Cell Movement; Cell Proliferation; Epithelial-Mesenchymal Transition; Flavonoids; Flavonols; Humans; Liver Neoplasms; Male; Mice; Mice, Inbred BALB C; Mice, Nude; NF-kappa B; Receptors, Dopamine; Signal Transduction; Transforming Growth Factor beta1; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2017 |
Dihydromyricetin-mediated inhibition of the Notch1 pathway induces apoptosis in QGY7701 and HepG2 hepatoma cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; bcl-2-Associated X Protein; Carcinoma, Hepatocellular; Cell Proliferation; Disease Progression; Down-Regulation; Flavonols; Flow Cytometry; Hep G2 Cells; Humans; Liver Neoplasms; Proto-Oncogene Proteins c-bcl-2; Receptor, Notch1; RNA Interference; RNA, Small Interfering; Signal Transduction; Up-Regulation | 2017 |
Fisetin Attenuates AKT Associated Growth Promoting Events in AflatoxinB1 Induced Hepatocellular Carcinoma.
Topics: Aflatoxin B1; Animals; Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Proliferation; Drug Screening Assays, Antitumor; Flavonoids; Flavonols; Liver Neoplasms; Male; Proto-Oncogene Proteins c-akt; Rats; Structure-Activity Relationship | 2018 |
Discovery of a Prenylated Flavonol Derivative as a Pin1 Inhibitor to Suppress Hepatocellular Carcinoma by Modulating MicroRNA Biogenesis.
Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Cell Survival; Computer-Aided Design; Dose-Response Relationship, Drug; Drug Discovery; Drug Screening Assays, Antitumor; Flavonols; Humans; Liver Neoplasms; MicroRNAs; Molecular Structure; NIMA-Interacting Peptidylprolyl Isomerase; Real-Time Polymerase Chain Reaction; Structure-Activity Relationship; Time Factors | 2019 |
Dihydromyricetin suppresses the proliferation of hepatocellular carcinoma cells by inducing G2/M arrest through the Chk1/Chk2/Cdc25C pathway.
Topics: Carcinoma, Hepatocellular; cdc25 Phosphatases; Cell Proliferation; Checkpoint Kinase 1; Checkpoint Kinase 2; Flavonols; G2 Phase Cell Cycle Checkpoints; Gene Expression Regulation, Neoplastic; Hep G2 Cells; Humans; Liver Neoplasms; Protein Kinases; Signal Transduction | 2013 |
Dihydromyricetin promotes hepatocellular carcinoma regression via a p53 activation-dependent mechanism.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Cisplatin; Enzyme Activation; Flavonols; Hep G2 Cells; Humans; Liver; Liver Neoplasms; Male; Medicine, Chinese Traditional; Mice; Mice, Inbred BALB C; Mice, Nude; Phosphorylation; RNA Interference; RNA, Small Interfering; Signal Transduction; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays | 2014 |
Dihydromyricetin inhibits migration and invasion of hepatoma cells through regulation of MMP-9 expression.
Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Hepatocellular; Cell Adhesion; Cell Line, Tumor; Cell Movement; Cell Survival; Dose-Response Relationship, Drug; Down-Regulation; Flavonols; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Liver Neoplasms; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Mitogen-Activated Protein Kinases; Neoplasm Invasiveness; Phosphorylation; Protein Kinase C-delta; Signal Transduction; Time Factors | 2014 |
Dihydromyricetin induces mouse hepatoma Hepal-6 cell apoptosis via the transforming growth factor-β pathway.
Topics: Adenosine Triphosphate; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Flavonols; Liver Neoplasms; Mice; Models, Biological; NADPH Oxidase 4; NADPH Oxidases; Reactive Oxygen Species; Signal Transduction; Transforming Growth Factor beta | 2015 |
Dihydromyricetin Enhances the Chemo-Sensitivity of Nedaplatin via Regulation of the p53/Bcl-2 Pathway in Hepatocellular Carcinoma Cells.
Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Cell Line, Tumor; Drug Synergism; Flavonols; Humans; Liver Neoplasms; Organoplatinum Compounds; Proto-Oncogene Proteins c-bcl-2; Tumor Suppressor Protein p53 | 2015 |
Fisetin Modulates Antioxidant Enzymes and Inflammatory Factors to Inhibit Aflatoxin-B1 Induced Hepatocellular Carcinoma in Rats.
Topics: Aflatoxin B1; Animals; Antioxidants; Carcinoma, Hepatocellular; Flavonoids; Flavonols; Interleukin-1alpha; Liver Neoplasms, Experimental; Male; Neoplasm Proteins; Oxidative Stress; Oxidoreductases; Rats; Tumor Necrosis Factor-alpha | 2016 |
Chemical characterization and bioactive properties of Geranium molle L.: from the plant to the most active extract and its phytochemicals.
Topics: Animals; Antioxidants; Carcinoma, Hepatocellular; Cell Line, Tumor; Chemical and Drug Induced Liver Injury; Fatty Acids, Essential; Flavones; Flavonoids; Flavonols; Free Radical Scavengers; Geranium; Glycosides; Humans; Hydrolyzable Tannins; Lipid Peroxidation; Nutritive Value; Phytochemicals; Plant Extracts; Portugal; Primary Cell Culture; Swine; Tocopherols | 2016 |
5,6-Dihydroxy-3,7,4'-trimethoxyflavonol induces G2/M cell cycle arrest and apoptosis in human hepatocellular carcinoma cells.
Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Caspase 3; Caspase 9; Cyclin B1; Cytochromes c; Drug Design; Flavonoids; Flavonols; G2 Phase Cell Cycle Checkpoints; Hep G2 Cells; Humans; Indoles; Liver Neoplasms; Membrane Potential, Mitochondrial; Mitochondria; Molecular Structure; Proto-Oncogene Proteins c-bcl-2; Structure-Activity Relationship | 2016 |
Chemical analysis and screening as anticancer agent of anthocyanin-rich extract from Uva Caimarona ( Pourouma cecropiifolia Mart.) fruit.
Topics: Anthocyanins; Antineoplastic Agents; Breast Neoplasms; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Survival; Chromatography, High Pressure Liquid; Ecosystem; Ericaceae; Female; Flavonols; Fruit; Humans; Liver Neoplasms; Magnetic Resonance Spectroscopy; Mass Spectrometry; Plant Extracts; Tropical Climate | 2010 |
Inhibitory effects of quercetin on aflatoxin B1-induced hepatic damage in mice.
Topics: Aflatoxin B1; Animals; Body Weight; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Survival; Chemical and Drug Induced Liver Injury; Chromatography, High Pressure Liquid; Flavonols; Glutathione; Humans; Liver; Male; Malondialdehyde; Mice; Mice, Inbred ICR; Organ Size; Quercetin; Reactive Oxygen Species | 2010 |
Inhibitory activity of diacylglycerol acyltransferase (DGAT) and microsomal triglyceride transfer protein (MTP) by the flavonoid, taxifolin, in HepG2 cells: potential role in the regulation of apolipoprotein B secretion.
Topics: Acyltransferases; Anti-Inflammatory Agents, Non-Steroidal; Apolipoproteins B; Carcinoma, Hepatocellular; Carrier Proteins; Diacylglycerol O-Acyltransferase; Enzyme-Linked Immunosorbent Assay; Flavonols; Humans; Liver Neoplasms; Quercetin; Tumor Cells, Cultured | 2004 |
In vitro anti-tumor activity of isorhamnetin isolated from Hippophae rhamnoides L. against BEL-7402 cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Nucleus; Chromatography, High Pressure Liquid; Flavonols; G1 Phase; Hippophae; Humans; Liver Neoplasms; Quercetin | 2006 |
Anti-proliferative and pro-apoptotic effect of Smilax glabra Roxb. extract on hepatoma cell lines.
Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Caspase 3; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cytochromes c; Drugs, Chinese Herbal; Flavonols; Gene Expression; Humans; Inhibitory Concentration 50; Liver Neoplasms; Membrane Potential, Mitochondrial; Mitochondria; Mitogen-Activated Protein Kinases; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerases; Smilax; Spirostans | 2008 |
Wogonin and fisetin induction of apoptosis through activation of caspase 3 cascade and alternative expression of p21 protein in hepatocellular carcinoma cells SK-HEP-1.
Topics: Antineoplastic Agents; Apoptosis; Blotting, Western; Carcinoma, Hepatocellular; Caspase 1; Caspase 3; Caspases; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Enzyme Activation; Flavanones; Flavonoids; Flavonols; Flow Cytometry; Humans; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 2002 |